Pathstone Family Office’s Compugen CGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding CGEN
AIM
NAMA
RSCM
Pathstone Family Office's CGEN Position: Q1 2022 in Review
Pathstone Family Office sold out of Compugen (CGEN) in Q1 2022, closing a stake of 23,922 shares — an estimated $103K sold.
Pathstone Family Office first reported a position in CGEN in Q4 2021 and held it in 1 quarter. The position peaked at $103K in Q4 2021. 110 funds tracked by Wall St. Rank hold CGEN as of Q1 2022.
- Pathstone Family Office reported no remaining Compugen position as of Q1 2022 after selling out during the quarter.
- Pathstone Family Office sold 23,922 Compugen shares in Q1 2022, an estimated $103K.
- Pathstone Family Office first reported a position in Compugen in Q4 2021 and held it in 1 quarter.
- Pathstone Family Office's Compugen position peaked at $103K in Q4 2021.
- 110 funds tracked by Wall St. Rank held Compugen as of Q1 2022.
Based on Pathstone Family Office's 13F filing for Q1 2022, filed 16 May 2022.